- Report
- September 2026
- 191 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- May 2026
- 150 Pages
Global
From €5408EUR$5,950USD£4,650GBP
- Report
- June 2026
- 144 Pages
Global
From €2726EUR$2,999USD£2,344GBP
€3635EUR$3,999USD£3,125GBP
- Report
- September 2026
- 185 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 194 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 199 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 198 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 195 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 185 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- July 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- July 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- September 2026
- 484 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- September 2026
- 248 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- July 2026
- 160 Pages
Global
From €3018EUR$3,320USD£2,595GBP
€3772EUR$4,150USD£3,243GBP
- Report
- April 2026
- 208 Pages
Global
From €3500EUR$4,125USD£3,115GBP
- Report
- October 2025
- 83 Pages
Middle East
From €4090EUR$4,500USD£3,517GBP
- Report
- February 2023
- 127 Pages
Global
From €2272EUR$2,500USD£1,954GBP

The Fluorescent Immunoassay (FIA) market is a segment of the In Vitro Diagnostics (IVD) industry. FIA is a type of immunoassay that uses fluorescent labels to detect and quantify antigens or antibodies in a sample. It is a highly sensitive and specific method of testing, and is used in a variety of clinical and research applications. FIA is often used to detect and measure hormones, proteins, and other biomarkers in the body. It is also used to detect and quantify infectious agents, such as bacteria and viruses. FIA is a cost-effective and reliable method of testing, and is used in a variety of clinical settings.
Some of the major companies in the FIA market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more